Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 51.32$. Average daily volumn in 3 months 28.09M. Market cap 294.40B

Stock symbol : PFE. Exchange : NYSE. Currency : USD
Lastest price : 52.47$. Total volume : 29.52M. Market state POSTPOST
Click reload if you want to check the lastest price on market!!!

Pfizer Inc. (PFE)
Last Price

Previous Close50.65
Day Range51.13-52.70
Bid52.47 x 1.8k
Ask52.48 x 2.2k
Average Volume28.09M
Market Cap294.4B
52 Week Range38.48-61.71
Trailing P/E12.03
Foward P/E1.00
Dividend (Yield %)3.16%
Ex-Dividend Date2022-05-12

Financial Details

According to Pfizer Inc.'s financial reports the company's revenue in 2021 were 81.29B an increase( +97.56%) over the years 2020 revenue that were of 41.65B. In 2021 the company's total earnings were 21.98B while total earnings in 2020 were 9.16B( +133.33%).

Loading ...


Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 trea... tment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Market Cap:
Total Assets:
Total Cash:

News about "Pfizer Inc."

Pfizer will give $107,000 to Colorado to settle lawsuit over failed coupons

Source from : Denver Post on - 12 hours ago

About 1,500 Coloradans will receive a refund from Pfizer after the pharmaceutical company failed to honor coupons for three medications, according to the Colorado Attorney Generalโ€™s Office. Pfizer has ...See details»


Pfizer, NIH Mulling Study For Longer Paxlovid Course To Combat Reinfections

Source from : YAHOO!Finance - 1 days ago

The U.S. National Institutes of Health and Pfizer Inc (NYSE: PFE) are discussing testing a longer course of COVID-19 antiviral treatment Paxlovid, required to prevent reinfections, White House Chief ...See details»

Pfizer a Top 25 Dividend Giant With 3.17% Yield (PFE)

Source from : Nasdaq - 1 days ago

Pfizer Inc (Symbol: PFE) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $33.49B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a ...See details»


CDC advisers recommend Pfizer COVID-19 booster shot for kids ages 5 to 11

Source from : MarketWatch - 1 days ago

Experts advising the CDC on vaccines recommended that children age 5 to 11 receive the newly authorized COVID booster shot from Pfizer Inc. and BioNTech SE.See details»


Pfizer's tight Paxlovid rein symies drug combination research

Source from : Crain's New York - 2 days ago

Pfizer hasnโ€™t started any combination trials in people, and a review of the database shows no outpatient studies combining Paxlovid, the mainstay U.S. Covid therapy, with other ...See details»


$2.07 Earnings Per Share Expected for Pfizer Inc. (NYSE:PFE) This Quarter

Source from : Defense World - 3 days ago

Wall Street analysts expect that Pfizer Inc. (NYSE:PFE โ€“ Get Rating) will post $2.07 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have ...See details»


CDC Recommends Pfizer/BioNTech COVID-19 Booster Shots For Kids Aged 5-11 Years

Source from : YAHOO!Finance - 22 hours ago

The Centers for Disease Control and Prevention recommended that children ages 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).See details»


Pfizer Inc. (NYSE: PFE) Finds That Paxlovid Cannot Prevent COVID-19 Infection

Source from : MarketWatch - 8 days ago

Pfizer Inc. (NYSE: PFE) has found that its Paxlovid pill might not effectively prevent COVID-19 in people who have come in contact with infected individuals. Paxlovid is an oral drug which the Food ...See details»


Switzerland buys Pfizer's COVID-19 antiviral Paxlovid

Source from : Nasdaq - 21 hours ago

Switzerland signed a contract to buy Pfizer's anti-viral drug Paxlovid to treat Covid-19, it said on Friday. BERLIN, May 20 (Reuters) - Switzerland signed a contract to buy Pfizer's anti-viral drug ...See details»


Rollout of Pfizer COVID-19 Vaccine Saved Lives, Health Care Dollars

Source from : St. Louis Post-Dispatch - 1 days ago

Manuela Di Fusco, from Pfizer Inc. in New York City, and colleagues developed a combined Markov decision tree model to compare clinical and economic outcomes of the Pfizer-BioNTech COVID-19 vaccine ...See details»


Pfizer to spend $11.6B on migraine treatment maker Biohaven

Source from : Associated Press - 10 days ago

Pfizer is starting to put its COVID-19 cash influx to use by spending $11.6 billion to venture deeper into a new treatment area. The New York vaccine and cancer drug maker said Tuesday it will use ...See details»


CDC gives final approval for Pfizer's 5-11 kids booster shot

Source from : Crain's Detroit - 1 days ago

Younger children across the U.S. are now eligible to receive a COVID-19 booster shot developed by Pfizer Inc. and BioNTech SE after the head of the Centers for Disease Control and Prevention granted ...See details»

Pfizer Inc. (NYSE:PFE) Expected to Post Quarterly Sales of $30.75 Billion

Source from : Defense World - 5 days ago

Brokerages predict that Pfizer Inc. (NYSE:PFE โ€“ Get Rating) will announce sales of $30.75 billion for the current quarter, according to Zacks. Three analysts have made estimates for Pfizerโ€™s earnings.See details»


Pfizerโ€™s Covid-19 Booster Cleared for 5- to 11-Year-Olds

Source from : Wall Street Journal - 3 days ago

The authorization by U.S. health regulators expands booster access to about 28 million youngsters.See details»